3221 Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice. (September 2015) - Krekeler, G.; Neuhof, A.; Dreyling, M.; Hess, G.; Kalanovic, D.